Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.323, 2001-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antiviral HCV therapy: give drug users a fair go
Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. :
Access to resources
Recommend
Truncated therapy the way to go for HCV
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. :
Blocking HCV entry as potential antiviral therapy
By Vercauteren Koen Leroux-Roels Geert Meuleman Philip
Future Virology, Vol. 7, Iss. 6, 2012-06 ,pp. :
HCV NS2/3 protease: a future antiviral drug target?
Future Virology, Vol. 4, Iss. 5, 2009-09 ,pp. :